| Adam Lecroy, PA-C | |
|
17800 S Camp Williams Rd, Bluffdale, UT 84065-4905 | |
| (801) 878-5076 | |
| Not Available |
| Full Name | Adam Lecroy |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 17800 S Camp Williams Rd, Bluffdale, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497916712 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adam Lecroy, PA-C 776 W 1875 S, Lehi, UT 84043-7425 Ph: (614) 946-1061 | Adam Lecroy, PA-C 17800 S Camp Williams Rd, Bluffdale, UT 84065-4905 Ph: (801) 878-5076 |
News Archive
Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.
An exciting new study conducted by Children's Hospital Oakland Research Institute scientists identified that an injection of the protein apolipoprotein A-V may reduce high triglyceride levels in the blood and subsequently reduce coronary artery disease. Like cholesterol, elevated levels of triglyceride, a fat in the blood, is associated with the increased risk of heart disease—the number one cause of death in the United States.
BioClinica, Inc., a global provider of clinical trial management solutions, today announced a new release of Trident IWR, the latest addition to its best-in-class suite of eClinical applications.
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients.
› Verified 9 days ago
Mr. Brady Mark Watkins, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13825 S Redwood Rd, Bluffdale, UT 84065 Phone: 801-254-9700 |